Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teriparatide in Japanese Patients With Osteoporosis
NCT00433160Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2007
- Primary completion
- Sep 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teriparatide in osteoporosis, sponsored by Eli Lilly and Company. Started Jan 2007; status: completed.
02
Drugs
teriparatide
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00433160.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433160.